Synthego is a genome engineering company specializing in CRISPR guide RNA (gRNA) synthesis and molecular diagnostics reagents. They provide GMP-grade synthetic guide RNAs, Cas9 nucleases, and base editors for cell and gene therapy developers. The company has cleared 14+ INDs and produced 200+ clinical sgRNA batches. Synthego declared bankruptcy and is not a drug manufacturer -- it supplies critical starting materials (gRNAs) to biopharma companies developing CRISPR-based therapies.
GMP guide RNA synthesis, CRISPR reagents, molecular diagnostics enzymes, IND-supporting sgRNA manufacturing
1 site worldwide
No reviews available yet.
No documents available.